[1] Thaloor D, Singh AK, Sidhu GS, et al.Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin[J]. Cell Growth Differ, 1998, 9(4):305-312. [2] Westerfield M, Wegner J, Jegalian BG.Specific activation of mammalian Hox promoters in mosaic transgenic zebrafish[J]. Genes Dev, 1992, 6(4):591-598. [3] Rubinstein AL.Zebrafish:from disease modeling to drug discovery[J].Current Opinion in Drug Discovery & Development, 2003, 6(2):218-223. [4] Child S, chen JN, Garrity DM,et al.Patterning of angiogenesis in the zebrafish embryo[J]. Development, 2002, 12(9):973-982. [5] Cross LM, Cook MA, Lin S, et al.Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay[J].Arterioscler Thromb Vasc Biol, 2003, 23:911-912. [6] Mirella B, Domenico R, Stefania N, et al.Antiangiogenic and Vascular-Targeting Activity of the Microtubule-Destabilizing trans-Resveratrol Derivative 3,5,4-Trimethoxystilbene[J]. Mol Pharmacol, 2005, 67:1451-1459. [7] 王思锋, 王希敏, 侯海荣, 等. 有机助溶剂对血管生成斑马鱼模型的适用性研究[J]. 实验动物与比较医学, 2008, 28(4):238-241. [8] Igura K, Ohta T, Kuroda Y, et al. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett, 2001, 28; 171(1):11-16. [9] LIN ming-tsan,men-luh YEN, ia-yi LIN, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation[J]. Mol Pharmacol, 2003, 5(64) :1029-1036. [10] 庆林. 透皮吸收促进剂的研究应用[J].中华实用中西医杂志, 2001, 1(14):11. [11] ItoY, OgisoT, IwakiM. Thermodynamic study on enhancementof percutaneous penetration of drugs by azone[J]. Pharmacobiodyn,1988, 11(11): 749-757. [12] Afouna M.I,Fincher T K, Zaghlou A.et al. Effect of Azone upon the in vivo antiviralefficacy ofcidofoviroracyclo vir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairlessmice[J]. Pharm,2003, 253(I-2):159-168. |